Namenda is used for treating moderate to severe dementia in people with Alzheimer's disease. It cannot cure the disease, but may help improve memory, attention, reason, language, and the ability to perform simple daily tasks. Occasionally, healthcare providers may also recommend off-label Namenda uses, such as for the prevention of migraines and the treatment of ADHD and dementia due to other causes.
Namenda® (memantine hydrochloride) is a prescription medication approved for the treatment of moderate to severe Alzheimer's disease.
Alzheimer's disease is a type of dementia that affects a person's thought process, memory, and language, with no known cause or cure. Common symptoms of Alzheimer's disease may include:
- Memory loss
- Poor judgment
- Deterioration of language skills
- Impaired ability to understand visual information
- Mood swings
Early signs of Alzheimer's disease are often confused with normal age-related changes. Eventually, the disease destroys a person's ability to think, process information, and function.
The recommended Alzheimer's treatment varies, depending on the different stages of Alzheimer's. Alzheimer's disease medications are usually key in the treatment of the condition. Namenda has been approved for the treatment of moderate to severe Alzheimer's disease. It is not a cure for Alzheimer's, nor does it slow down the progression of the disease or prevent it from occurring. It can, however, help improve memory, attention, reason, language, and the ability to perform simple daily tasks.
Namenda is classified as an NMDA receptor antagonist. "NMDA" stands for N-methyl-D-asparate. It is thought that some of the symptoms of Alzheimer's may be related to changes in NMDA receptors that allow for abnormal, excessive excitation of the receptors by glutamate (a neurotransmitter brain chemical). Namenda works by binding to the NMDA receptor and preventing excessive excitation by glutamate. Currently, no other Alzheimer's medications work like Namenda.